Failed hair regrowth after PRP treatment not medical negligence: NCDRC

Introduction: The Intersection of Aesthetic Expectations and Legal Liability

In a landmark observation that provides significant relief to the medical fraternity, particularly those practicing in the aesthetic and dermatological domains, the National Consumer Disputes Redressal Commission (NCDRC) has clarified the boundaries of medical negligence. The case, involving failed hair regrowth after Platelet-Rich Plasma (PRP) treatment, underscores a fundamental legal principle: a doctor cannot be held liable for negligence simply because a treatment did not yield the desired aesthetic result. This ruling, delivered by the Bench of Presiding Member AVM J Rajendra and Member Anoop Kumar Mendiratta, sets a crucial precedent for how “failure of cure” is interpreted in the context of elective cosmetic procedures.

As a Senior Advocate, I view this judgment as a reinforcing pillar for the ‘Bolam Test’ and subsequent Supreme Court rulings that distinguish between a genuine lack of care and the inherent unpredictability of medical science. In the realm of consumer litigation, where patients often equate payment with guaranteed outcomes, the NCDRC has re-established that the medical profession operates on the standard of reasonable care, not a guarantee of success.

Background of the Case: Lifecell International Private Limited vs. The Complainant

The dispute originated when a consumer approached the District and subsequently the State Consumer Disputes Redressal Commission, alleging deficiency in service against Lifecell International Private Limited. The complainant had undergone PRP treatment—a popular non-surgical procedure for hair restoration—expecting a significant reversal of hair loss. When the treatment failed to produce visible regrowth, the complainant sought compensation, alleging that the service provider had failed to deliver on its promises.

The lower commissions had initially ruled in favor of the consumer, directing the service provider to compensate the patient. However, the matter reached the NCDRC via a revision petition. The core of the legal debate rested on whether the absence of a positive physiological change (hair growth) constitutes a ‘deficiency in service’ or ‘medical negligence’ under the Consumer Protection Act.

The NCDRC’s Deliberation on Medical Outcomes

The NCDRC Bench scrutinized the clinical records and the nature of PRP therapy. The Commission noted that medical science, especially in aesthetic treatments, is subject to individual biological variations. The Bench observed that while a patient might feel aggrieved by the lack of results, the law requires proof that the medical professional or the facility deviated from standard operating procedures (SOPs). The mere fact that the hair did not grow back as expected does not, in itself, establish a breach of duty.

Defining Medical Negligence in the Indian Legal Landscape

To understand the gravity of this ruling, one must look at how Indian courts define medical negligence. The benchmark remains the Supreme Court’s judgment in Jacob Mathew vs. State of Punjab, which clarified that a professional may be held liable for negligence on one of two findings: either he was not possessed of the requisite skill which he professed to have possessed, or, he did not exercise, with reasonable competence in the given case, the skill which he did possess.

The Distinction Between Negligence and Failure of Treatment

In the context of the PRP case, the NCDRC highlighted that “failure of treatment” is not synonymous with “negligence.” In any medical intervention, there is an inherent risk of failure. In aesthetic procedures like PRP, factors such as the patient’s age, hormonal balance, lifestyle, and genetic predisposition play a massive role in the final outcome. The legal system protects a doctor who follows an accepted practice in the medical community, even if another school of thought exists or if the treatment fails to produce the desired effect.

The Role of the Bolam Test

The “Bolam Test” (from the English case Bolam v Friern Hospital Management Committee) is frequently cited in Indian courts. It suggests that a doctor is not negligent if he acts in accordance with a practice accepted as proper by a responsible body of medical men skilled in that particular art. The NCDRC’s decision in the Lifecell case aligns with this, suggesting that if the PRP procedure was conducted according to dermatological standards, the lack of regrowth is a biological failure, not a legal one.

The Specifics of PRP Treatment and Informed Consent

Platelet-Rich Plasma therapy involves drawing a patient’s blood, processing it to concentrate the platelets, and injecting it back into the scalp. It is touted as a regenerative treatment. However, no clinical literature suggests a 100% success rate. This brings us to the critical legal concept of “Informed Consent.”

The Necessity of Realistic Expectations

One of the defense’s strongest points in such cases is the documentation provided to the patient before the procedure. If the service provider clearly states that results vary and are not guaranteed, the consumer’s claim for negligence weakens significantly. The NCDRC’s ruling implies that consumers must be aware of the elective nature of these treatments. A “contract for service” in medicine is not a “contract for a specific result” unless explicitly guaranteed in writing—which most medical practitioners wisely avoid.

The Duty to Warn

While the doctor is protected against failed outcomes, they still have a “duty to warn” the patient of potential failure. If a clinic promises “guaranteed hair regrowth” in its marketing material and the treatment fails, the case might shift from medical negligence to “unfair trade practice” under the Consumer Protection Act. However, in the absence of such fraudulent misrepresentation, the medical failure remains outside the purview of negligence.

Implications for the Aesthetic Medicine Industry

The NCDRC’s stance is a significant win for clinics offering hair transplants, PRP, botox, and other cosmetic enhancements. The industry has seen a surge in litigation from dissatisfied clients who expect “photoshopped” results in real life.

Protection Against Frivolous Litigation

This judgment serves as a shield against frivolous litigation. It prevents disgruntled patients from using the Consumer Courts as a tool for “refunds” when biological processes do not align with their expectations. It reinforces that the burden of proof lies on the complainant to show exactly where the medical professional erred in their protocol.

Standardization of Clinical Documentation

For practitioners, this case is a reminder to strengthen their documentation. Every PRP session should be backed by:

• Pre-procedure counseling notes.
• Signed informed consent forms acknowledging that results are not guaranteed.
• Detailed logs of the equipment used (centrifuge speeds, kit types, etc.).
• Photographic evidence of the baseline condition.

These documents are the first line of defense when a consumer files a complaint alleging lack of results.

Analyzing the NCDRC Bench’s Findings

The Bench of AVM J Rajendra and Anoop Kumar Mendiratta emphasized that the lower commissions had erred by focusing on the ‘outcome’ rather than the ‘process.’ In medical jurisprudence, the focus must always remain on whether the ‘process’ adhered to the ‘standard of care.’ By setting aside the orders against Lifecell International, the NCDRC has sent a clear message: the judiciary will not entertain claims that seek to penalize doctors for the limitations of human biology.

The Concept of ‘Reasonable Care’

The Commission reiterated that the law does not require a doctor to be a miracle worker. They are only required to exercise ‘reasonable care.’ If the PRP was prepared correctly and administered in the correct plane of the scalp using sterile techniques, the doctor’s duty is fulfilled. The subsequent reaction of the hair follicles to the plasma is beyond the doctor’s control.

Consumer Rights vs. Professional Liability: Striking a Balance

While this judgment favors the medical community, it does not give a free pass to clinics. It is essential to distinguish between a “failed result” and “harm caused.” If a PRP treatment resulted in an infection, scarring, or any other physical injury due to unhygienic conditions or faulty technique, the doctor would absolutely be liable for medical negligence.

When Does Failed Treatment Become Negligence?

A failed treatment can cross into negligence if:

• The practitioner was not qualified to perform the procedure.
• The equipment used was substandard or unsterilized.
• The patient was not screened for contraindications.
• The practitioner made false claims of a guaranteed cure to induce the patient.

In the Lifecell case, the NCDRC found no such evidence of procedural deviation, hence the dismissal of the negligence charge.

Conclusion: A Pragmatic Approach to Medical Law

The NCDRC’s ruling in the case of failed hair regrowth after PRP treatment is a masterclass in the pragmatic application of consumer law. It recognizes the nuances of medical science and protects professionals from being penalized for the unpredictability of human physiology. For the legal community, it reinforces the necessity of expert evidence and a focus on procedural standards over emotional or aesthetic disappointment.

As the cosmetic industry continues to grow in India, we can expect more such cases. However, this precedent ensures that the definition of “negligence” remains rooted in the failure of “duty and care” rather than the failure of “hope and expectation.” Both practitioners and consumers must take away a vital lesson from this: medicine is an art based on science, and while the art can be perfected, the science of the human body remains a realm of probabilities, not certainties.

Ultimately, the National Commission has upheld the dignity of the medical profession by ensuring that the threat of litigation does not stifle the practice of elective medicine. It encourages a transparent relationship between the doctor and the patient, built on the foundation of informed consent and realistic goals.